# Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

> **NCT06197295** · PHASE4 · RECRUITING · sponsor: **Mackay Memorial Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Urinary Bladder, Overactive
- Effect of Drug

## Interventions

- **DRUG:** Solifenacin with vaginal estrogen cream
- **DRUG:** Combination pharmacotherapy

## Key facts

- **NCT ID:** NCT06197295
- **Lead sponsor:** Mackay Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-16
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06197295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06197295, "Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06197295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*